F21L (p.Phe21Leu) variant of APOA1 (Apolipoprotein A-I)

F21L (p.Phe21Leu) in APOA1 (Apolipoprotein A-I) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes population frequency data and structural context.

F21L (p.Phe21Leu) variant details